We are live on ! Find out more
CAM

Claret Asset Management Portfolio holdings

AUM $837M
1-Year Est. Return 25.51%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+25.51%
3 Year Est. Return
+63.76%
5 Year Est. Return
+90.36%
10 Year Est. Return
–
AUM
$837M
AUM Growth
-$24.6M
Cap. Flow
+$11.6M
Cap. Flow %
1.38%
Top 10 Hldgs %
36.6%
Holding
399
New
16
Increased
144
Reduced
94
Closed
45

Top Buys

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$23.4M
2
SFM icon
Sprouts Farmers Market
SFM
+$16.5M
3
CDE icon
Coeur Mining
CDE
+$5.94M
4
CNI icon
Canadian National Railway
CNI
+$4.41M
5
GIB icon
CGI
GIB
+$2.92M

Top Sells

Rank Stock Value
1
QIPT
Quipt Home Medical
QIPT
+$11.4M
2
NGD
New Gold Inc
NGD
+$4.79M
3
ESI icon
Element Solutions
ESI
+$3.96M
4
KVUE icon
Kenvue
KVUE
+$1.69M
5
MSFT icon
Microsoft
MSFT
+$1.68M

Sector Composition

Rank Sector Weight
1 Technology 20.49%
2 Financials 18.2%
3 Healthcare 17.87%
4 Communication Services 11.43%
5 Consumer Staples 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSTR icon
226
Landstar System
LSTR
$7.19B
$263K 0.03%
1,641
– –
HLT icon
227
Hilton Worldwide
HLT
$73.6B
$262K 0.03%
862
+1
+0.1% +$303
WFC icon
228
Wells Fargo
WFC
$267B
$262K 0.03%
3,291
+5
+0.2% +$429
WST icon
229
West Pharmaceutical
WST
$25.6B
$262K 0.03%
1,046
-11
-1% -$2.74K
BIO icon
230
Bio-Rad Laboratories Class A
BIO
$8.05B
$261K 0.03%
938
– –
DOV icon
231
Dover
DOV
$29.3B
$260K 0.03%
1,249
-6
-0.5% -$1.28K
PG icon
232
Procter & Gamble
PG
$353B
$257K 0.03%
1,776
-10
-0.6% -$1.52K
ORLY icon
233
O'Reilly Automotive
ORLY
$71.5B
$256K 0.03%
2,769
+1
+0% +$94
WSM icon
234
Williams-Sonoma
WSM
$26.9B
$254K 0.03%
1,393
– –
ACN icon
235
Accenture
ACN
$88.5B
$253K 0.03%
1,278
+135
+12% +$31.5K
GD icon
236
General Dynamics
GD
$99.7B
$253K 0.03%
737
+6
+0.8% +$2.13K
NBIX icon
237
Neurocrine Biosciences
NBIX
$17.2B
$253K 0.03%
1,923
-8
-0.4% -$1.06K
SITE icon
238
SiteOne Landscape Supply
SITE
$4.78B
$253K 0.03%
1,899
– –
AIT icon
239
Applied Industrial Technologies
AIT
$12.3B
$252K 0.03%
948
– –
DGX icon
240
Quest Diagnostics
DGX
$23.2B
$252K 0.03%
1,288
– –
FCN icon
241
FTI Consulting
FCN
$4.96B
$252K 0.03%
1,425
+1
+0.1% +$171
EW icon
242
Edwards Lifesciences
EW
$50.6B
$251K 0.03%
3,133
-15
-0.5% -$1.24K
SSD icon
243
Simpson Manufacturing
SSD
$7.97B
$250K 0.03%
1,457
– –
FTNT icon
244
Fortinet
FTNT
$118B
$249K 0.03%
3,045
– –
IDXX icon
245
Idexx Laboratories
IDXX
$45.4B
$249K 0.03%
442
– –
THC icon
246
Tenet Healthcare
THC
$17.2B
$249K 0.03%
1,317
– –
BLD
247
DELISTED
TopBuild
BLD
$248K 0.03%
705
– –
DVA icon
248
DaVita
DVA
$15B
$248K 0.03%
+1,616
New +$219K
MGM icon
249
MGM Resorts International
MGM
$12B
$248K 0.03%
6,693
+1
+0% +$36
GWW icon
250
W.W. Grainger
GWW
$66.2B
$247K 0.03%
226
– –
8 9
10
11 12

Similar funds

ES
Eagle Strategies New York $837M AUM 21.63% 1-Year Est. Return
SAIG
Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return
DLP
De Lisle Partners Poole, United Kingdom $836M AUM 58.41% 1-Year Est. Return
FPGK
Financial Partners Group (Kansas) Overland Park, Kansas $836M AUM 21.04% 1-Year Est. Return
MPM
MBB Public Markets Chicago, Illinois $839M AUM 20.48% 1-Year Est. Return
MCM
Mattern Capital Management Lakewood, Colorado $835M AUM 3.68% 1-Year Est. Return
MAP
Managed Asset Portfolios Rochester, Michigan $834M AUM 33.97% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Claret Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Claret Asset Management held 399 positions worth $837M, down 2.9% from $862M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Claret Asset Management's Q1 2026 filing shows 16 new, 144 increased, 94 reduced and 45 closed positions. Its largest new stake was Indivior Pharmaceuticals: 707,267 shares worth $21.6M. The largest sale was Quipt Home Medical, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Claret Asset Management's largest Q1 2026 buy was Indivior Pharmaceuticals: 707,267 shares worth $21.6M.
  • Claret Asset Management added most to Canadian National Railway in Q1 2026, an estimated $4.41M increase.
  • Claret Asset Management's biggest Q1 2026 reduction was Element Solutions, cutting an estimated $3.96M.
  • Claret Asset Management fully exited Quipt Home Medical in Q1 2026, selling an estimated $11.4M.
  • Claret Asset Management's ten largest holdings make up 37% of its $837M portfolio in Q1 2026.
  • Claret Asset Management opened 16 new positions and closed 45 in Q1 2026.
  • Claret Asset Management's portfolio value fell 2.9% quarter-over-quarter to $837M.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.